TOI — Oncology Institute Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Oncology Institute, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	6	114	73.8	82.9	49.7
Net Total Accounts Receivable
Net Total Receivables	17.3	21.2	40.4	42.9	48.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29.7	154	130	143	112
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.1	4.19	33	40.1	37.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	65.7	203	262	209	173
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.6	29.8	29.7	34.8	52.2
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	37.6	99.3	138	152	169
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	28.1	104	123	57	3.59
Total Liabilities & Shareholders' Equity	65.7	203	262	209	173
Total Common Shares Outstanding
Total Preferred Shares Outstanding